Deutsch English Français

Contact

EP2266557

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2266557

EP2266557 - COMBINATION OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND IMMUNOSUPPRESSING AGENT, AND PHARMACEUTICAL COMPOSITION COMPRISING THESE COMPONENTS [Right-click to bookmark this link]
Former [2010/52]	METHOD OF UTILIZATION OF COMBINATION OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND IMMUNOSUPPRESSING AGENT, AND PHARMACEUTICAL COMPOSITION COMPRISING THESE COMPONENTS
	[2013/09]
Status	No opposition filed within time limit Status updated on 20.06.2014 Database last updated on 07.10.2024
Most recent event Tooltip	20.06.2014	No opposition filed within time limit	published on 23.07.2014 [2014/30]
Applicant(s)	For all designated states Toyama Chemical Co., Ltd. 2-5 Nishishinjuku 3-Chome Shinjuku-ku Tokyo 160-0023 / JP
	[2010/52]
Inventor(s)	01 / AIKAWA, Yukihiko c/o TOYAMA CHEMICAL CO. LTD. Toyama Works 4-1 Shimookui 2-Chome Toyama-Shi Toyama 930-8508 / JP
	02 / SHIOZAWA, Shunichi 11-6 Takenodai 2-Chome Nishi-ku Kobe-Shi Hyogo 651-2274 / JP
	[2013/33]
Former [2010/52]	01 / AIKAWA, Yukihiko c/o TOYAMA CHEMICAL CO. LTD. Toyama Works 4-1 Shimookui 2-Chome Toyama-Shi Toyama 930-8508 / JP
	02 / SHIOZAWA, Shunichi 11-6 Takenodai 2-Chome Nishi-ku Kobe-Shi Hyogo 651-2274 / JP
Representative(s)	Blodig, Wolfgang Wächtershäuser & Hartz Patentanwaltspartnerschaft mbB Weinstrasse 8 80333 München / DE
	[N/P]
Former [2013/33]	Blodig, Wolfgang Wächtershäuser & Hartz Patentanwaltspartnerschaft Ottostrasse 4 80333 München / DE
Former [2010/52]	Blodig, Wolfgang Wächtershäuser & Hartz Patentanwaltspartnerschaft Weinstrasse 8 80333 München / DE
Application number, filing date	09735250.4	20.04.2009
	[2010/52]
	WO2009JP57860
Priority number, date	JP20080111295	22.04.2008 Original published format: JP 2008111295
	[2010/52]
Filing language	JA
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2009131098
	Date:	29.10.2009
	Language:	JA
	[2009/44]
	Type:	A1 Application with search report
	No.:	EP2266557
	Date:	29.12.2010
	Language:	EN
	[2010/52]
	Type:	B1 Patent specification
	No.:	EP2266557
	Date:	14.08.2013
	Language:	EN
	[2013/33]
Search report(s)	International search report - published on:	JP	29.10.2009
	(Supplementary) European search report - dispatched on:	EP	22.08.2011
Classification	IPC:	A61K31/194, A61K31/42, A61K31/423, A61K31/519, A61K31/5377, A61K31/573, A61K45/06, A61P29/00, A61P37/06, A61P43/00	[2010/52]
	CPC:	A61K45/06 (EP,US); A61K31/194 (EP,US); A61K31/42 (EP,US); A61K31/423 (EP,US); A61K31/519 (EP,US); A61K31/5377 (EP,US); (+) A61K31/573 (EP,US); A61P1/04 (EP); A61P1/16 (EP); A61P17/00 (EP); A61P19/00 (EP); A61P19/02 (EP); A61P21/00 (EP); A61P29/00 (EP); A61P37/00 (EP); A61P37/02 (EP); A61P37/06 (EP); A61P43/00 (EP) (-)
	C-Set:	A61K31/194, A61K2300/00 (EP,US); A61K31/423, A61K2300/00 (US,EP); A61K31/42, A61K2300/00 (US,EP); A61K31/519, A61K2300/00 (US,EP); (+) A61K31/5377, A61K2300/00 (EP,US); A61K31/573, A61K2300/00 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/52]
Title	German:	KOMBINATION AUS EINEM BENZOPHENONDERIVAT ODER EINEM SALZ DARAUS UND EINEM IMMUNSUPPRESSIVEN WIRKSTOFF SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT DIESEN KOMPONENTEN	[2013/09]
	English:	COMBINATION OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND IMMUNOSUPPRESSING AGENT, AND PHARMACEUTICAL COMPOSITION COMPRISING THESE COMPONENTS	[2013/09]
	French:	COMBINAISON D'UN DÉRIVÉ DE BENZOPHÉNONE OU D'UN SEL DE CELUI-CI ET D'UN AGENT IMMUNOSUPPRESSEUR, ET COMPOSITION PHARMACEUTIQUE COMPRENANT CES COMPOSANTS	[2013/09]
	Former [2010/52]	VERFAHREN ZUR VERWENDUNG EINER KOMBINATION AUS EINEM BENZOPHENONDERIVAT ODER EINEM SALZ DARAUS UND EINEM IMMUNSUPPRESSIVEN WIRKSTOFF SOWIE PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT DIESEN KOMPONENTEN
	Former [2010/52]	METHOD OF UTILIZATION OF COMBINATION OF BENZOPHENONE DERIVATIVE OR SALT THEREOF AND IMMUNOSUPPRESSING AGENT, AND PHARMACEUTICAL COMPOSITION COMPRISING THESE COMPONENTS
	Former [2010/52]	PROCÉDÉ D'UTILISATION D'UNE COMBINAISON D'UN DÉRIVÉ DE BENZOPHÉNONE OU D'UN SEL DE CELUI-CI ET D'UN AGENT IMMUNOSUPPRESSEUR, ET COMPOSITION PHARMACEUTIQUE COMPRENANT CES COMPOSANTS
Entry into regional phase	06.10.2010	Translation filed
	06.10.2010	National basic fee paid
	06.10.2010	Search fee paid
	06.10.2010	Designation fee(s) paid
	06.10.2010	Examination fee paid
Examination procedure	06.10.2010	Examination requested [2010/52]
	31.01.2012	Amendment by applicant (claims and/or description)
	21.03.2013	Communication of intention to grant the patent
	28.06.2013	Fee for grant paid
	28.06.2013	Fee for publishing/printing paid
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.03.2013
Opposition(s)	15.05.2014	No opposition filed within time limit [2014/30]
Fees paid	Renewal fee
	07.04.2011	Renewal fee patent year 03
	14.03.2012	Renewal fee patent year 04
	12.04.2013	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[Y]EP1445249 (TOYAMA CHEMICAL CO LTD [JP], et al) [Y] 1-16 * claims 1,8 * * page 9, paragraph 0035 *;
		[Y]WO2007138997 (TOYAMA CHEMICAL CO LTD [JP], et al) [Y] 1-16 * the whole document *;
		[Y] - KROOT ERIC-JAN A ET AL, "Oral pulsed dexamethasone therapy in early rheumatoid arthritis: a pilot study.", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES JUN 2006 LNKD- PUBMED:16855157, (200606), vol. 1069, ISSN 0077-8923, pages 300 - 306, XP002656569 [Y] 1-16 * page 300, abstract * DOI: http://dx.doi.org/10.1196/annals.1351.028
		[Y] - RAVELLI A ET AL, "Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate", JOURNAL OF PEDIATRICS, MOSBY-YEAR BOOK, ST. LOUIS, MO, US, vol. 133, no. 2, ISSN 0022-3476, (19980801), pages 262 - 265, (19980801), XP027398734 [Y] 1-16 * page 262, column l, paragraph 1 *
	International search	[Y]JP2003040776 (SANKYO CO);
		[Y]WO03042150 (TOYAMA CHEMICAL CO LTD [JP], et al);
		[Y]JP2004501147 (ATHEROGENICS, INC.);
		[Y]JP2007500223 (WYETH);
		[YP] - AIKAWA Y ET AL., "Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1", NATURE BIOTECHNOLOGY, (200807), vol. 26, no. 7, pages 817 - 823, XP008141319 DOI: http://dx.doi.org/10.1038/nbt1412
	by applicant	WO03042150
		- BERTRAM G KATZUNG, Basic & Clinical Pharmacology, MCGRAW-HILL COMPANIES, (2004), pages 940 - 950
		- THE NEW ENGLAND JOURNAL OF MEDICINE, (1996), vol. 334, pages 1287 - 1291
		- W GREENE ET AL., Protective Groups in Organic Synthesis, JOHN WILEY & SONS, INC, (1999), pages 369 - 453
		- W GREENE ET AL., Protective Groups in Organic Synthesis, JOHN WILEY & SONS, INC, (1999), pages 494 - 615
		- W GREENE ET AL., Protective Groups in Organic Synthesis, JOHN WILEY & SONS, INC, (1999), pages 17 - 245

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p